Tumour endothelial cells transcriptomics in response to Doxorubicin treatment.

ABSTRACT: Despite its established role in breast cancer treatment, Doxorubicin remains a challenge in breast cancer treatment as its long-term success is prevented by adaptive resistance mechanisms that extend beyond cancer cell intrinsic alterations. Our study in a MMTV-PyMT-driven mouse breast cancer model reveals that prolonged Doxorubicin exposure triggers a significant reprogramming of the tumour vasculature, substantially altering the angiocrine landscape and shaping treatment outcomes.

ORGANISM(S): Mus musculus

PROVIDER: GSE311784 | GEO | 2026/07/01

REPOSITORIES: GEO